OXYTOCIN INHIBITS PROLIFERATION OF HUMAN BREAST-CANCER CELL-LINES

被引：0
|
作者：
CASSONI, P [1 ]
SAPINO, A [1 ]
NEGRO, F [1 ]
BUSSOLATI, G [1 ]
机构：
[1] UNIV TURIN, DEPT BIOMED SCI & ONCOL, I-10126 TURIN, ITALY
来源：
VIRCHOWS ARCHIV | 1994年 / 425卷 / 05期
关键词：
OXYTOCIN; BREAST CANCER; CELL GROWTH;
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
In this study we show that treatment of MDA-MB231 hormone-independent human breast cancer cells with oxytocin (OT) or with the OT analogue F314 induces significant growth inhibition together with a change in cell phenotype. In MCF7 and T47D human breast cancer cells, OT inhibits oestrogen-induced cell growth. In these same cells, OT administration significantly enhances the inhibitory effect of tamoxifen on cell proliferation. MDA-MB231, MCF7 and T47D cells all express mRNA specific for the OT receptor. These data suggest that it may be possible to inhibit breast cancer growth using OT and OT analogues.
引用
收藏
页码：467 / 472
页数：6
相关论文
共 50 条
  • [21] BREAST-CANCER CELL-LINES CHARACTERIZED FROM 3 PATIENTS
    SWANSON, TL
    MORGAN, RT
    QUINN, LA
    SEMPLE, TU
    WOODS, LK
    MOORE, GE
    IN VITRO-JOURNAL OF THE TISSUE CULTURE ASSOCIATION, 1980, 16 (03): : 247 - 248
  • [22] THE ANTIPROLIFERATIVE EFFECTS OF SYNTHETIC RETINOIDS AND AROTINOIDS ON HUMAN OVARIAN AND BREAST-CANCER CELL-LINES
    TAYLOR, CM
    BLANCHARD, B
    WETHERALL, NT
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 360 - 360
  • [23] NEUROMEDIN-B INDUCES MITOGENESIS IN 3 HUMAN BREAST-CANCER CELL-LINES
    BURNS, DM
    NELSON, J
    REGULATORY PEPTIDES, 1992, 39 (2-3) : 275 - 275
  • [24] EFFECT OF ESTROGEN AND TAMOXIFEN (TAM) ON HUMAN BREAST-CANCER CELL-LINES - IMMUNOCYTOCHEMICAL STUDIES
    ITOH, H
    SHINODA, R
    AKATSUKA, Y
    KAKUDOH, K
    OSAMURA, Y
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1990, 38 (07) : 1025 - 1025
  • [25] HUMAN BREAST-CANCER CELL-LINES RESISTANT TO PURE ANTIESTROGENS ARE SENSITIVE TO TAMOXIFEN TREATMENT
    LYKKESFELDT, AE
    LARSEN, SS
    BRIAND, P
    INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (04) : 529 - 534
  • [26] REGULATION OF P53 PROTEIN EXPRESSION IN HUMAN BREAST-CANCER CELL-LINES
    VOJTESEK, B
    LANE, DP
    JOURNAL OF CELL SCIENCE, 1993, 105 : 607 - 612
  • [27] GROWTH OF HUMAN BREAST-CANCER CELL-LINES IS INHIBITED BY THE SOMATOSTATIN ANALOG BIM23014
    PREVOST, G
    FOEHRLE, E
    THOMAS, F
    PIHAN, I
    VEBER, N
    STARZEC, A
    ISRAEL, L
    ENDOCRINOLOGY, 1991, 129 (01) : 323 - 329
  • [28] DIFFERENTIAL REGULATION OF MATRIX METALLOPROTEINASE-2 ACTIVATION IN HUMAN BREAST-CANCER CELL-LINES
    MAITI, SN
    YU, M
    BUENO, J
    TIRGARI, RH
    PALAOMARCO, FL
    PULYAEVA, H
    THOMPSON, EW
    INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL, 1994, 732 : 456 - 458
  • [29] GENETIC AND IMMUNOCHEMICAL ANALYSIS OF MUTANT P53 IN HUMAN BREAST-CANCER CELL-LINES
    BARTEK, J
    IGGO, R
    GANNON, J
    LANE, DP
    ONCOGENE, 1990, 5 (06) : 893 - 899
  • [30] PROLACTIN RECEPTOR ANTAGONISTS THAT INHIBIT THE GROWTH OF BREAST-CANCER CELL-LINES
    FUH, G
    WELLS, JA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (22) : 13133 - 13137
12345